DXCM Q1 2024 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$921M+24.2% YoY

Gross Profit

$562M61.0% margin

Operating Income

$101M11.0% margin

Net Income

$146M15.9% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

-11.0%

Cash Flow

Operating Cash Flow

$209M

Free Cash Flow

$152M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$6.5B

Total Liabilities

$4.2B

Stockholders' Equity

$2.2B

Cash & Equivalents

$851M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$921M	$742M	+24.2%
Gross Profit	$562M	$463M	+21.5%
Operating Income	$101M	$47M	+114.2%
Net Income	$146M	$49M	+201.2%

Geographic Segments

UNITED STATES

$653M71%

Non-US

$268M29%